11 Apr 2023
On the occasion of the Annual Meeting of the American Association for Cancer Research (AACR, 14-19 Apr 2023, Orlando, FL, USA), Epimune will present 2 abstracts of an ongoing research project together with the University Hospital at the Martin Luther University Halle-Wittenberg (UKH).
In the project, which is funded by the German Federal Ministry of Education and Research (BMBF), scientists from Epimune and UKH are testing samples from patients with B-cell non-Hodgkin lymphoma (NHL) for changes in the immune system using Epimune's Epigenetic Immune Cell Quantification Technology. The goal of the project is to develop minimally invasive tests based on Epimune's proprietary technology to improve early detection and prediction of disease progression in B-cell NHL.
Both abstracts can be viewed online at: